These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Prevalence of metabolic disorders among family members of patients with polycystic ovary syndrome]. Benítez R, Sir-Petermann T, Palomino A, Angel B, Maliqueo M, Pérez F, Calvillán M. Rev Med Chil; 2001 Jul; 129(7):707-12. PubMed ID: 11552437 [Abstract] [Full Text] [Related]
10. Role of obesity and adiposity in polycystic ovary syndrome. Diamanti-Kandarakis E. Int J Obes (Lond); 2007 Nov; 31 Suppl 2():S8-13; discussion S31-2. PubMed ID: 17968437 [Abstract] [Full Text] [Related]
15. Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence. Talbott EO, Zborowskii JV, Boudraux MY. Minerva Ginecol; 2004 Feb; 56(1):27-39. PubMed ID: 14973408 [Abstract] [Full Text] [Related]
16. Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome. Diamanti-Kandarakis E, Christakou C, Kandarakis H. Minerva Endocrinol; 2007 Mar; 32(1):35-47. PubMed ID: 17353865 [Abstract] [Full Text] [Related]
17. Insulin resistance and polycystic ovary syndrome. Galluzzo A, Amato MC, Giordano C. Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):511-8. PubMed ID: 18657405 [Abstract] [Full Text] [Related]